New Technologies that will Impact the Global Pharmaceutical Packaging Industry : Customisation is the New Formula

LONDON, Dec. 18, 2014 /PRNewswire/ -- Key Questions This Study Will Answer

How big is the pharmaceutical packaging industry?
Which are the key factors driving the industry and what are the restraints hampering its growth?
Who are the news makers in this industry?
Which are the key companies and regulations to focus on during 2014?2015?
Which are the new technologies that can help pharmaceutical companies gain an edge over their competitors and reduce packaging costs?

Executive Summary

•The pharmaceutical industry is undergoing a rapid transition, from being a supply-driven industry to a demand and service-driven one in 2014. Manufacturing efficiency and responsiveness are likely to play a major role in driving growth in the future.
•Distribution of pharmaceutical products has become more global than ever. Mass customisation of packaging to permit its use in multiple markets is the industry's current area of focus. The distribution of pharmaceutical products is currently driven by environmental issues, including sustainability, pricing, quality assurance (QA), and customisation, and is likely to continue that way in the future.
•In 2015, the packaging industry will be ready to witness technologies that remind patients to take their medication and enable doctors to remotely monitor the proper use of medicines that were prescribed. Smart labels are ready for mass production (US Patent July 2014). Though awareness is low and adoption is slow, the market will witness changes due to the introduction of smart tags.
•Smart tags are expected to check and track drug packages and help manufacturers in keeping supply chains on surveillance.
•Under the sub-segments, prefilled syringes are expected to be the fastest growing aseptic packaging type. The demand is expected to grow at an estimated x % each year in major markets such as the United States (US) and the European Union (EU).
•Due to the health issues involved, a few governments have started considering a ban on the usage of PET packages for liquid drug formulations (as of September 2014, India).
•Pharmaceutical packaging manufacturers are also focusing on clinical research organisations (CROs) and early-stage drug manufacturers (besides the conventional pharmaceutical companies). Personalisation and customisation are driving the packaging industry to offer services from the early stages to product launch.
•The United States, the European Union, and Japan account for more than x - x % of the global market for pharmaceutical packaging. This trend is expected to shift towards China, Brazil, and India with the growth of the pharmaceutical and CRO markets.
•China has currently become the focus market for most of the pharmaceutical packaging manufacturers. Relocation of major multinational companies (MNCs) to special economic zones (SEZs) has been one of the major drivers for its growth. India closely follows China in terms of growth and has been considered as a potential market for the future.
•Amcor, Schott AG (the parent company of Schott Singapore Pte. Ltd), CCL Industries, and MeadWestvaco Corp. (MWV) are some of the major manufacturers operating in the pharmaceutical packaging industry.

Failures in Packaging are a Key Reason for Losses in the Cash-Strapped Pharmaceutical Industry

Key Reasons for Failures:
•Drug boxes are increasingly using pictograms even though several studies have shown that they are often difficult to interpret.
•There are cases where boxes of generics have included standard dosing schedules that are not always appropriate and may create a risk of dosing errors with potentially serious consequences.
•Uneven information quality, discrepancies between different sections, and out-of-date information have also led to withdrawals of packages by pharmaceutical companies.
•The use of colours is frequently inappropriate. In particular, irrelevant information is often highlighted unnecessarily, while other, important information is barely visible.
•The labelling of some injectable drugs has been found to be barely legible. The various models of plastic ampoules that are gradually replacing glass ampoules can be dangerous because they resemble other plastic ampoules containing products that are administered via different routes.


Download the full report: https://www.reportbuyer.com/product/2568509/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/new-technologies-that-will-impact-the-global-pharmaceutical-packaging-industry--customisation-is-the-new-formula-300012022.html

SOURCE ReportBuyer

Related Links

http://www.reportbuyer.com